Depomed Announces US Food and Drug Administration Approval of Gralise (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia
Links shared publicly online about this topic.
- 535total visits
Depomed Announces US Food and Drug Administration Approval of Gralise (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia
Gralise (gabapentin) is used to treat post-herpetic neuralgia. Includes Gralise side effects, interactions and indications.
View full resource at drugs.com
Tags: Migraine Prevention Medication, Seizure Medication, Diet and Nutrition, Drug, FDA, Neurontin, Epilepsy Medication
Most Recently Shared on February 3, 2011 at 12:16 am By:
Depomed Announces FDA Approval of Gralise (gabapentin) for Treatment of Post-Herpetic Neuralgia - http://bit.ly/hLaEa7
Depomed Announces US Food and Drug Administration Approval of Gralise (gabapentin) Once-Daily Tablets for Treatment of Post-Herpetic Neuralgia
drugs.com — “Gralise (gabapentin) is used to treat post-herpetic neuralgia. Includes Gralise side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 1, 2011 at 11:10 pm By:
Drugs and Devices OW OW Health
Depomed Announces US Food and Drug Administration Approval of Gralise (gabapentin) Once-Daily Tablets for ... http://bit.ly/eeb147 #drug
Advertisement
